667 related articles for article (PubMed ID: 10666364)
1. Vasculogenic mimicry and tumor angiogenesis.
Folberg R; Hendrix MJ; Maniotis AJ
Am J Pathol; 2000 Feb; 156(2):361-81. PubMed ID: 10666364
[TBL] [Abstract][Full Text] [Related]
2. Comparison of tumor-associated vasculatures in uveal and cutaneous melanomas.
Bhat P; Jakobiec FA; Folberg R
Semin Ophthalmol; 2009; 24(3):166-71. PubMed ID: 19437353
[TBL] [Abstract][Full Text] [Related]
3. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.
Maniotis AJ; Folberg R; Hess A; Seftor EA; Gardner LM; Pe'er J; Trent JM; Meltzer PS; Hendrix MJ
Am J Pathol; 1999 Sep; 155(3):739-52. PubMed ID: 10487832
[TBL] [Abstract][Full Text] [Related]
4. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma.
Hendrix MJ; Seftor EA; Hess AR; Seftor RE
Nat Rev Cancer; 2003 Jun; 3(6):411-21. PubMed ID: 12778131
[TBL] [Abstract][Full Text] [Related]
5. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
Hess AR; Seftor EA; Gardner LM; Carles-Kinch K; Schneider GB; Seftor RE; Kinch MS; Hendrix MJ
Cancer Res; 2001 Apr; 61(8):3250-5. PubMed ID: 11309274
[TBL] [Abstract][Full Text] [Related]
6. Vasculogenic mimicry.
Folberg R; Maniotis AJ
APMIS; 2004; 112(7-8):508-25. PubMed ID: 15563313
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns.
Folberg R; Arbieva Z; Moses J; Hayee A; Sandal T; Kadkol S; Lin AY; Valyi-Nagy K; Setty S; Leach L; Chévez-Barrios P; Larsen P; Majumdar D; Pe'er J; Maniotis AJ
Am J Pathol; 2006 Oct; 169(4):1376-89. PubMed ID: 17003493
[TBL] [Abstract][Full Text] [Related]
8. Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry.
Seftor RE; Seftor EA; Kirschmann DA; Hendrix MJ
Mol Cancer Ther; 2002 Nov; 1(13):1173-9. PubMed ID: 12479698
[TBL] [Abstract][Full Text] [Related]
9. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma.
Massi D; Franchi A; Paglierani M; Ketabchi S; Borgognoni L; Reali UM; Santucci M
Hum Pathol; 2004 Apr; 35(4):496-502. PubMed ID: 15116332
[TBL] [Abstract][Full Text] [Related]
10. [Vasculogenic mimicry--potential target for tumor therapy].
Yue WY; Chen ZP
Ai Zheng; 2006 Jul; 25(7):914-6. PubMed ID: 16831290
[TBL] [Abstract][Full Text] [Related]
11. Vasculogenic mimicry: how convincing, how novel, and how significant?
McDonald DM; Munn L; Jain RK
Am J Pathol; 2000 Feb; 156(2):383-8. PubMed ID: 10666365
[No Abstract] [Full Text] [Related]
12. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
Seftor RE; Seftor EA; Koshikawa N; Meltzer PS; Gardner LM; Bilban M; Stetler-Stevenson WG; Quaranta V; Hendrix MJ
Cancer Res; 2001 Sep; 61(17):6322-7. PubMed ID: 11522618
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry.
Zhang R; Chen X; Chen S; Tang J; Chen F; Lin Y; Reinach PS; Yan X; Tu L; Duan H; Qu J; Hou Q
Cell Oncol (Dordr); 2022 Aug; 45(4):557-572. PubMed ID: 35716258
[TBL] [Abstract][Full Text] [Related]
14. Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2).
Su F; Li B; Wang J; Xu X; Ren R; Li L; Gao F; Liu X
Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):411-9. PubMed ID: 19043732
[TBL] [Abstract][Full Text] [Related]
15. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry.
Ruf W; Seftor EA; Petrovan RJ; Weiss RM; Gruman LM; Margaryan NV; Seftor RE; Miyagi Y; Hendrix MJ
Cancer Res; 2003 Sep; 63(17):5381-9. PubMed ID: 14500372
[TBL] [Abstract][Full Text] [Related]
16. Modeling the behavior of uveal melanoma in the liver.
Folberg R; Leach L; Valyi-Nagy K; Lin AY; Apushkin MA; Ai Z; Barak V; Majumdar D; Pe'er J; Maniotis AJ
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2967-74. PubMed ID: 17591861
[TBL] [Abstract][Full Text] [Related]
17. Remodeling of the microenvironment by aggressive melanoma tumor cells.
Hendrix MJ; Seftor EA; Kirschmann DA; Quaranta V; Seftor RE
Ann N Y Acad Sci; 2003 May; 995():151-61. PubMed ID: 12814947
[TBL] [Abstract][Full Text] [Related]
18. Intravitreally Injected HCmel12 Melanoma Cells Serve as a Mouse Model of Tumor Biology of Intraocular Melanoma.
Kilian MM; Loeffler KU; Pfarrer C; Holz FG; Kurts C; Herwig MC
Curr Eye Res; 2016; 41(1):121-8. PubMed ID: 25658144
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis, vasculogenic mimicry and vascular invasion in cutaneous malignant melanoma - implications for therapeutic strategies and targeted therapies.
Chung HJ; Mahalingam M
Expert Rev Anticancer Ther; 2014 May; 14(5):621-39. PubMed ID: 24506089
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical Study of Vasculogenic Mimicry and Angiogenesis in Melanocytic Tumors of the Eye and the Periocular Area.
Spiliopoulos K; Peschos D; Batistatou A; Ntountas I; Papoudou-Bai A; Zioga A; Agnantis N; Kitsos G
Anticancer Res; 2017 Mar; 37(3):1113-1120. PubMed ID: 28314272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
